CNBC June 16, 2023
Key Points
– Bristol Myers Squibb has sued the Biden administration over Medicare’s new powers to negotiate drug prices under the Inflation Reduction Act.
– The drugmaker said its blood thinner Eliquis will be subject to the negotiations later this year.
– Bristol Myer Squibb’s complaint mirrors the arguments made last week by Merck, the first company to sue over the law.
– The U.S. Chamber of Commerce also sued the Biden administration last week.
Bristol Myers Squibb on Friday sued the Biden administration over Medicare‘s new powers to slash drug prices, the third such lawsuit to be filed against the program in a matter of days.
The lawsuit filed in federal district court in New Jersey argues the Medicare...
Today's Sponsors
Today's Sponsor